Amarin Corp PLC: Executive & Board Changes Announced
Ticker: AMRN · Form: 8-K · Filed: Mar 28, 2025 · CIK: 897448
| Field | Detail |
|---|---|
| Company | Amarin Corp PLC\UK (AMRN) |
| Form Type | 8-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, board-change, personnel
Related Tickers: AMRN
TL;DR
Amarin shakes up C-suite and board, new CMO and director appointed.
AI Summary
On March 28, 2025, Amarin Corporation plc filed an 8-K report detailing the departure of Dr. Steven L. Smith as Chief Medical Officer and the appointment of Dr. Karim Mikhail as his successor. The filing also announced the election of Ms. Sarah J. Kelly to the Board of Directors and changes to the compensation committee.
Why It Matters
Significant changes in key executive and board positions can impact a company's strategic direction and operational execution.
Risk Assessment
Risk Level: medium — Changes in key leadership roles can introduce uncertainty regarding future strategy and performance.
Key Players & Entities
- Amarin Corporation plc (company) — Registrant
- Dr. Steven L. Smith (person) — Departing Chief Medical Officer
- Dr. Karim Mikhail (person) — Appointed Chief Medical Officer
- Ms. Sarah J. Kelly (person) — Elected to Board of Directors
- March 28, 2025 (date) — Date of Report
FAQ
Who has been appointed as the new Chief Medical Officer for Amarin Corporation plc?
Dr. Karim Mikhail has been appointed as the new Chief Medical Officer.
Who has departed from their role as Chief Medical Officer?
Dr. Steven L. Smith has departed from his role as Chief Medical Officer.
Has there been any change in Amarin's Board of Directors?
Yes, Ms. Sarah J. Kelly has been elected to the Board of Directors.
What is the effective date of these reported changes?
The earliest event reported is dated March 28, 2025.
Are there any changes mentioned regarding the compensation committee?
Yes, the filing indicates changes to the compensation committee.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 by Dr. Steven L. Smith regarding AMARIN CORP PLC\UK (AMRN).